Chinese-based genetics company BGI Group is collecting women's health data from a prenatal test taken by more than 8 million women globally, Reuters reports. The test was created in collaboration with the People's Liberation Army of China and marketed around the world starting in 2013. BGI stores leftover blood samples and genetic data for population research, but the company maintained its collection is in compliance with relevant privacy laws, including explicit consent for collection and destruction of data after five years.